Ether hydrochloride → (r)-5,11-Dihydro-5-[1-(3-pyrrolidinophenethyl)pyrrolidin-2-ylmethyl]-dibenzo[b,e][1,4]oxazepine dihydrochloride
反応式
[ClH:1].C(OCC)C.[N:7]1([C:12]2[CH:13]=[C:14]([CH:38]=[CH:39][CH:40]=2)[CH2:15][CH2:16][N:17]2[CH2:21][CH2:20][CH2:19][C@@H:18]2[CH2:22][N:23]2[C:29]3[CH:30]=[CH:31][CH:32]=[CH:33][C:28]=3[CH2:27][O:26][C:25]3[CH:34]=[CH:35][CH:36]=[CH:37][C:24]2=3)[CH2:11][CH2:10][CH2:9][CH2:8]1>ClCCl>[ClH:1].[ClH:1].[N:7]1([C:12]2[CH:13]=[C:14]([CH:38]=[CH:39][CH:40]=2)[CH2:15][CH2:16][N:17]2[CH2:21][CH2:20][CH2:19][C@@H:18]2[CH2:22][N:23]2[C:29]3[CH:30]=[CH:31][CH:32]=[CH:33][C:28]=3[CH2:27][O:26][C:25]3[CH:34]=[CH:35][CH:36]=[CH:37][C:24]2=3)[CH2:11][CH2:10][CH2:9][CH2:8]1参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
2.0 ml of 2 M hydrogen chloride/diethyl ether was added to a solution of (R)-5,11-dihydro-5-[1-(3-pyrrolidinophenethyl)pyrrolidin-2-ylmethyl]dibenzo[b,e][1,4]oxazepine (208 mg) in dichloromethane (2 ml), and they were stirred together for 2 hours. The solvent was evaporated under reduced pressure. The obtained residue was solidified by stirring it in hexane. The solid thus precipitated was taken by the filtration to obtain the title compound in the form of a light brown solid (220 mg, 91%).
後処理
- customThe solvent was evaporated under reduced pressure
- stirringby stirring it in hexane
- customThe solid thus precipitated
- filtrationwas taken by the filtration
出典と根拠
- ORDレコード
- ord-3e3623e7f1c44c4aa5e093cb67b95be7
- 出典データセット
- uspto-grants-2008_01
- 特許番号
- US07320973B2
反応ノート
読み込み中…